Healthpeak Properties Announces Leadership Changes in Lab Investments and Development.
ByAinvest
Wednesday, Aug 27, 2025 7:08 am ET1min read
DOC--
Denis Sullivan brings over two decades of experience in life science real estate, having previously served as Chief Investment Officer and Chief Financial Officer at BioMed Realty. He also co-founded Foundation Capital Ventures, where he helped develop life science properties in leading innovation hubs. Under his new role, Sullivan will drive Healthpeak's portfolio-wide Lab investment strategy and oversee leasing and asset management activities in San Diego, a key market for life science innovation [1].
Mike Dorris, who has been promoted to Head of West Coast Development & Construction for Lab, will expand Healthpeak's expertise in specialized lab design and construction. This move will enhance the company's development and redevelopment capabilities, ensuring it continues to create state-of-the-art spaces for medical breakthroughs [1].
These appointments reflect Healthpeak's commitment to the life science sector and its strategy to capture investment and leasing opportunities as the market recovers. The company aims to leverage Sullivan's investment leadership and Dorris's technical expertise to strengthen its platform from sourcing opportunities to delivering innovative solutions for tenants [1].
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company, specializing in high-quality real estate focused on healthcare discovery and delivery. For more information, visit www.healthpeak.com [1].
References:
[1] https://www.stocktitan.net/news/DOC/healthpeak-strengthens-life-science-leadership-with-addition-of-44scybfc3w6r.html
Healthpeak Properties has announced two executive changes: Denis Sullivan joins as Managing Director of Lab Investments & San Diego Market Lead, and Mike Dorris is promoted to Head of West Coast Development & Construction. Sullivan brings 20 years of life science real estate leadership experience, and Dorris will expand Healthpeak's lab design and construction capabilities. The moves position Healthpeak to capture investment and leasing opportunities as the life science market recovers.
Healthpeak Properties, Inc. (NYSE: DOC) has announced significant executive changes aimed at strengthening its position in the life science real estate sector. Denis Sullivan has joined the company as Managing Director of Lab Investments & San Diego Market Lead, while Mike Dorris has been promoted to Head of West Coast Development & Construction [1].Denis Sullivan brings over two decades of experience in life science real estate, having previously served as Chief Investment Officer and Chief Financial Officer at BioMed Realty. He also co-founded Foundation Capital Ventures, where he helped develop life science properties in leading innovation hubs. Under his new role, Sullivan will drive Healthpeak's portfolio-wide Lab investment strategy and oversee leasing and asset management activities in San Diego, a key market for life science innovation [1].
Mike Dorris, who has been promoted to Head of West Coast Development & Construction for Lab, will expand Healthpeak's expertise in specialized lab design and construction. This move will enhance the company's development and redevelopment capabilities, ensuring it continues to create state-of-the-art spaces for medical breakthroughs [1].
These appointments reflect Healthpeak's commitment to the life science sector and its strategy to capture investment and leasing opportunities as the market recovers. The company aims to leverage Sullivan's investment leadership and Dorris's technical expertise to strengthen its platform from sourcing opportunities to delivering innovative solutions for tenants [1].
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company, specializing in high-quality real estate focused on healthcare discovery and delivery. For more information, visit www.healthpeak.com [1].
References:
[1] https://www.stocktitan.net/news/DOC/healthpeak-strengthens-life-science-leadership-with-addition-of-44scybfc3w6r.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet